Arizona doctors hope two drugs could be used for COVID-19 treatment

By Peter Samore | KTAR 

A group of Arizona doctors believes two well-known drugs could team up to make one treatment to fight the coronavirus.

Arizona-based Translational Genomics Research Institute (TGen) will run a clinical trial with HonorHealth and 25 of its sickest COVID-19 patients, doctors from both entities announced in an online video conference Tuesday.

Atovaquone, which is an anti-malarial drug, and the antibiotic, azithromycin, commonly known as Z-Pak, fight pneumonia and other viruses.

“In case they ended up in the ICU, intubated and on a ventilator, where we could continue to administer the drug without having to change the formulation,” Dr. Michael Gordon, medical director at HonorHealth Research Institute, said.

READ ON:

Share this!

Additional Articles

Top master-planned communities for 2024

By AZ Big Media Here are the Top 10 master-planned communities in Arizona, based on public voting for the 2024 edition of Ranking Arizona, the state’s biggest and most comprehensive business opinion poll. Ranking Arizona

Read More »
News Categories

Get Our Twice Weekly Newsletter!

* indicates required

Rose Law Group pc values “outrageous client service.” We pride ourselves on hyper-responsiveness to our clients’ needs and an extraordinary record of success in achieving our clients’ goals. We know we get results and our list of outstanding clients speaks to the quality of our work.